Definitive Contract 36C26223C0115

Award Date 4/1/23
Potential Completion Date 9/30/24
Potential Value $124K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tucson, AZ 85723, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a firm fixed-price delivery order contract worth $13,320.50 to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for coagulation testing and does not have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers,...
This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $15,104,376.83, was awarded by the Department of Veterans Affairs (VA) and covers the provision of chemistry and immunoassay products and services. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, and it has no set-aside...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $157,436.96 contract, which did not have a set-aside designation, was for immunohistochemistry products and services. Roche Diagnostics has been awarded numerous federal contracts to provide medical equipment, supplies, and services to agencies such...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $293,728.80 contract is for the service, maintenance, and supply of Roche Ventana instruments, which are used for clinical testing, research, and healthcare delivery across various medical...
This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, worth $2,120,267.95, is a delivery order placed by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 10 for ROCHE VENTANA REAGENTS. The contract is a firm fixed-price arrangement with an ultimate completion date of April 22, 2025. Roche Diagnostics...
The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $342,604.03 Firm Fixed Price contract is for the supply of ROCHE EQUIPMENT SUPPLIES AND REAGENT and has a completion date of September 30, 2023. The contract is not set aside for any socioeconomic category. Roche Diagnostics holds several Indefinite Delivery Contracts and...
The Department of Veterans Affairs Veterans Health Administration awarded a $458,322.56 firm-fixed-price delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for molecular pathology products and services. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer that has provided medical equipment, reagents, and laboratory services to various federal agencies through prime contracts and subcontracts,...
This is a delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a component of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $126,829.78, is for the provision of Roche testing supplies. It is not designated as a set-aside contract. The contract is part of a...
This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $4,166.40 contract is for an annual service agreement with a completion date of December 31, 2024. Roche Diagnostics is not a set-aside awardee for this contract. The contract is part of Roche's existing...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $112,018.90 firm-fixed-price delivery order was placed against Roche's existing General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory Equipment (FSS-66-III). This order provides the VA with clinical chemistry...

This is a definitive contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $124,341.72 firm fixed-price contract is for laboratory maintenance services and does not have a set-aside designation. Roche Diagnostics has multiple significant Indefinite Delivery Vehicles and Blanket Purchase Agreements with federal agencies like the Department of Defense and Department of Veterans Affairs to provide medical diagnostic technologies and laboratory solutions. This contract award is likely part of Roche's broader portfolio of federal contract vehicles established under General Services Administration schedules for critical analyzers and in vitro diagnostics.

Generated 4/29/25, 9:53 AM